The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favourable safety…
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with…
Cancer risk increases with age and is often more aggressive and difficult to treat in…
Sleep deprivation has long been known to weaken the immune system. Now University of Florida…
Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced clinical…
A phase 1 study aiming to test tolerability of combination therapy with trastuzumab deruxtecan and…
Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily…
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were…
The latest findings, presented at the American Association for Cancer Research (AACR) Annual Meeting 2026,…
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different…